Research Appraisaldiagnostic

A Dataset of Widefield Fundus Images From Patients With Birdshot Chorioretinitis and Matched Control

Scientific dataFoulonneau, Thomas, Memmi, Caroline, Monnet, Dominique et al.6 June 2026DOI

Clinical Snapshot

70CEBM
Evidence: Moderatediagnostic

PICO Framework

P — Population742 eyes with birdshot chorioretinitis and 742 age- and sex-matched healthy control eyes
I — InterventionWidefield fundus photography imaging
C — ComparatorHealthy control eyes matched for age and sex
O — OutcomesClassification accuracy for distinguishing birdshot chorioretinitis from normal eyes using deep learning models (AUC up to 0.96)

Bottom Line

This study presents a large, standardized dataset of widefield fundus images from 742 eyes with birdshot chorioretinitis and matched controls, demonstrating high diagnostic accuracy (AUC 0.96) using deep learning classification. While the dataset size and longitudinal design are impressive strengths, the abstract lacks crucial methodological details including specific reference standard criteria, blinding procedures, and traditional diagnostic accuracy metrics. The clinical utility appears promising for supporting diagnosis of this rare inflammatory condition, particularly in tertiary centres with appropriate imaging capabilities. However, validation in independent populations and comparison with current diagnostic standards would strengthen the evidence base. Australian ophthalmologists should await full publication details and external validation before considering clinical implementation, though the approach shows potential for improving diagnostic accuracy in posterior uveitis evaluation.

Evidence: Moderate

Key Findings

  • P Value: Not reported

  • Effect Size: Area under ROC curve up to 0.96

  • Primary Outcome: Classification accuracy for distinguishing birdshot chorioretinitis from normal eyes

  • Nnt Or Sensitivity: Sensitivity and specificity not reported - only AUC provided

  • Confidence Interval: Not reported

Clinical Application

Requires widefield fundus photography capability and deep learning infrastructure - feasible in tertiary ophthalmology centres Relevant to Australian ophthalmology practice where birdshot chorioretinitis diagnosis can be challenging. Could support PBS applications for immunosuppressive therapy by providing objective diagnostic evidence. Aligns with RANZCO guidelines for posterior uveitis investigation. Patients presenting with posterior uveitis or suspected inflammatory chorioretinopathy requiring differential diagnosis

Abstract

Birdshot chorioretinitis is a rare uveitis where research is limited by the lack of large, publicly available imaging datasets. To address this gap, we present Birdshot-Wide, a standardized retinal imaging dataset comprising 5,042 widefield fundus photographs from 742 eyes with birdshot chorioretinitis (BSCR) and 1,310 images from 742 age-and sex- matched healthy eyes controls. The BSCR cohort is longitudinal, with a median follow-up of 4.31 years. Each image in the BSCR cohort was manually reviewed for quality and classified by dominant lesion subtype. To demonstrate its utility, the dataset was benchmarked on a classification task, where deep learning models trained to differentiate BSCR from control images achieved an area under the receiver operating characteristic curve of up to 0.96. This dataset, with its detailed metadata, provides a valuable resource for biomarker discovery, the development of automated diagnostic tools, and disease progression modeling.

References

  1. 1.Foulonneau, T., Memmi, C., Monnet, D., Brézin, A. P., & Vienne-Jumeau, A. (2026). A dataset of widefield fundus images from patients with birdshot chorioretinitis and matched control. Scientific Data. https://doi.org/10.1016/j.ajo.2021.03.059
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service